Delivery Order SPE2DR25D9239-SPE2DR26FFCB6
Award Date 2/12/26
Potential Completion Date 3/6/26
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, with a ceiling value of $11,591.04 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed against a single-award Indefinite Delivery Contract (SPE2DR) with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $14,195.52 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the company's single-award Indefinite Delivery Contract (SPE2DR) with DLA, established November 13, 2025, with a $499.9 billion ceiling and ultimate...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $18,031.94 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $3,167.01 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V indefinite delivery contract (contract SPE2DR, awarded November 13, 2025, with a $499.999 billion ceiling and completion date of December 31,...
- The Defense Logistics Agency issued a $3,184.64 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a DLA-administered indefinite delivery contract program with a $499.9 billion ceiling across multiple regional prime vendor contractors, structured to provide firm...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $2,492.64 for pharmaceutical products under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order is issued under the single-award Indefinite Delivery Contract SPE2DR, awarded...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $4,154.40 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for branded...
- The Defense Logistics Agency issued a $14,643.01 delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The parent IDC, awarded to DMS on November 13, 2025, carries a $499.999 billion ceiling and an ultimate completion date of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 7, 2026, with a ceiling value of $2,370.92 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, with a ceiling value of $1,310.22 for pharmaceutical products. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical...